Lemur catta isolate mLemCat1 chromosome 20, mLemCat1.pri, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Strepsirrhini; Lemuriformes; Lemuridae; Lemur.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036491.1.\nAssembly name: mLemCat1.pri\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGPY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 16-JUL-2021\nAssembly Method :: hifiasm v. 0.12-r304; purge_dups v.\n 1.2.5; bionano_solve v.\n Solve3.6.1_11162020; salsa2 v. v2.2;\n gEVAL manual curation v. 2021-07-16\nAssembly Name :: mLemCat1.pri\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 20.81x\nSequencing Technology :: Pacbio Sequel II CCS; 10X Genomics linked\n reads; Bionano Genomics DLS; Arima\n Genomics v1 Hi-C\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Lemur catta Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
COORDINATES: nucleotide motif:Rfam:12.0:RF02543
COORDINATES: nucleotide motif:Rfam:12.0:RF00002
COORDINATES: nucleotide motif:Rfam:12.0:RF01960
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC123625119, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123625119, transcript variant X5
uncharacterized LOC123625119, transcript variant X8
uncharacterized LOC123625119, transcript variant X7
uncharacterized LOC123625119, transcript variant X6
uncharacterized LOC123625119, transcript variant X3
uncharacterized LOC123625119, transcript variant X4
uncharacterized LOC123625119, transcript variant X2
uncharacterized LOC123625120, transcript variant X1
uncharacterized LOC123625120, transcript variant X5
uncharacterized LOC123625120, transcript variant X7
uncharacterized LOC123625120, transcript variant X6
uncharacterized LOC123625120, transcript variant X3
uncharacterized LOC123625120, transcript variant X4
uncharacterized LOC123625120, transcript variant X2
uncharacterized LOC123625118, transcript variant X1
uncharacterized LOC123625118, transcript variant X5
uncharacterized LOC123625118, transcript variant X8
uncharacterized LOC123625118, transcript variant X7
uncharacterized LOC123625118, transcript variant X6
uncharacterized LOC123625118, transcript variant X3
uncharacterized LOC123625118, transcript variant X4
uncharacterized LOC123625118, transcript variant X2
uncharacterized LOC123625121, transcript variant X2
uncharacterized LOC123625121, transcript variant X4
uncharacterized LOC123625121, transcript variant X3
uncharacterized LOC123625121, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 40 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
vacuolar protein sorting-associated protein 35
myosin light chain kinase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
myosin light chain kinase 3, transcript variant X3
myosin light chain kinase 3, transcript variant X2
myosin light chain kinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromosome 20 C16orf87 homolog, transcript variant X1
chromosome 20 C16orf87 homolog, transcript variant X3
UPF0547 protein C16orf87 homolog isoform X2
UPF0547 protein C16orf87 homolog isoform X1
chromosome 20 C16orf87 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member A2
neuropilin and tolloid like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 43 ESTs, 7 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuropilin and tolloid like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 39 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
integrin alpha FG-GAP repeat containing 1, transcript variant X1
T-cell immunomodulatory protein isoform X1
integrin alpha FG-GAP repeat containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 194 ESTs, 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
T-cell immunomodulatory protein isoform X2
phosphorylase kinase regulatory subunit beta, transcript variant X1
phosphorylase b kinase regulatory subunit beta isoform X1
phosphorylase kinase regulatory subunit beta, transcript variant X5
phosphorylase kinase regulatory subunit beta, transcript variant X2
phosphorylase kinase regulatory subunit beta, transcript variant X4
phosphorylase b kinase regulatory subunit beta isoform X4
phosphorylase b kinase regulatory subunit beta isoform X2
phosphorylase kinase regulatory subunit beta, transcript variant X3
phosphorylase b kinase regulatory subunit beta isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
general transcription factor IIH subunit 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, 5 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00618
ATP-binding cassette sub-family C member 12-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ATP-binding cassette sub-family C member 12-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
ATP binding cassette subfamily C member 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATP binding cassette subfamily C member 11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATP binding cassette subfamily C member 11, transcript variant X5
ATP binding cassette subfamily C member 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATP binding cassette subfamily C member 11, transcript variant X2
ATP-binding cassette sub-family C member 11 isoform X4
ATP-binding cassette sub-family C member 11 isoform X5
ATP-binding cassette sub-family C member 11 isoform X3
ATP-binding cassette sub-family C member 11 isoform X2
ATP-binding cassette sub-family C member 11 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00422
siah E3 ubiquitin protein ligase 1, transcript variant X2
siah E3 ubiquitin protein ligase 1, transcript variant X4
siah E3 ubiquitin protein ligase 1, transcript variant X1
siah E3 ubiquitin protein ligase 1, transcript variant X3
E3 ubiquitin-protein ligase SIAH1 isoform X1
E3 ubiquitin-protein ligase SIAH1 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, 10 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
COORDINATES: nucleotide motif:Rfam:12.0:RF00413
putative ankyrin repeat domain-containing protein 19
liver carboxylesterase 1-like, transcript variant X1
liver carboxylesterase 1-like, transcript variant X6
liver carboxylesterase 1-like, transcript variant X2
liver carboxylesterase 1-like, transcript variant X3
liver carboxylesterase 1-like, transcript variant X5
liver carboxylesterase 1-like, transcript variant X4
liver carboxylesterase 1-like isoform X1
liver carboxylesterase 1-like isoform X3
liver carboxylesterase 1-like isoform X2
liver carboxylesterase 1-like isoform X4
chromodomain-helicase-DNA-binding protein 9-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: chromodomain-helicase-DNA-binding protein 9-like
polycystic kidney disease protein 1-like 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: polycystic kidney disease protein 1-like 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
dihydroorotate dehydrogenase (quinone), mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dihydroorotate dehydrogenase (quinone), mitochondrial-like
uncharacterized LOC123625114, transcript variant X1
uncharacterized LOC123625114, transcript variant X6
uncharacterized LOC123625114, transcript variant X3
uncharacterized LOC123625114, transcript variant X5
uncharacterized LOC123625114, transcript variant X4
uncharacterized LOC123625114, transcript variant X2
NEDD4 binding protein 1, transcript variant X1
NEDD4 binding protein 1, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00612
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C16orf78 homolog
CTD nuclear envelope phosphatase 1 regulatory subunit 1, transcript variant X1
CTD nuclear envelope phosphatase 1 regulatory subunit 1, transcript variant X2
nuclear envelope phosphatase-regulatory subunit 1 isoform X2
nuclear envelope phosphatase-regulatory subunit 1 isoform X1
HEAT repeat containing 3, transcript variant X1
HEAT repeat-containing protein 3 isoform X1
HEAT repeat containing 3, transcript variant X2
HEAT repeat-containing protein 3 isoform X2
terminal nucleotidyltransferase 4B, transcript variant X2
terminal nucleotidyltransferase 4B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 ESTs, 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
terminal nucleotidyltransferase 4B, transcript variant X1
terminal nucleotidyltransferase 4B, transcript variant X5
terminal nucleotidyltransferase 4B, transcript variant X4
terminal nucleotidyltransferase 4B isoform X3
terminal nucleotidyltransferase 4B isoform X1
terminal nucleotidyltransferase 4B isoform X5
terminal nucleotidyltransferase 4B isoform X4
terminal nucleotidyltransferase 4B isoform X2
adenylate cyclase 7, transcript variant X7
adenylate cyclase 7, transcript variant X8
adenylate cyclase 7, transcript variant X5
adenylate cyclase 7, transcript variant X2
adenylate cyclase 7, transcript variant X9
adenylate cyclase 7, transcript variant X10
adenylate cyclase 7, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenylate cyclase 7, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenylate cyclase 7, transcript variant X12
adenylate cyclase 7, transcript variant X3
adenylate cyclase 7, transcript variant X1
adenylate cyclase 7, transcript variant X6
adenylate cyclase 7, transcript variant X4
bromodomain containing 7, transcript variant X2
bromodomain containing 7, transcript variant X1
bromodomain-containing protein 7 isoform X2
bromodomain-containing protein 7 isoform X1
NKD inhibitor of WNT signaling pathway 1, transcript variant X2
protein naked cuticle homolog 1 isoform X2
NKD inhibitor of WNT signaling pathway 1, transcript variant X3
protein naked cuticle homolog 1 isoform X3
NKD inhibitor of WNT signaling pathway 1, transcript variant X1
protein naked cuticle homolog 1 isoform X1
NKD inhibitor of WNT signaling pathway 1, transcript variant X4
protein naked cuticle homolog 1 isoform X4
uncharacterized LOC123625061, transcript variant X3
uncharacterized LOC123625061, transcript variant X1
uncharacterized LOC123625061, transcript variant X2
nucleotide binding oligomerization domain containing 2, transcript variant X3
nucleotide binding oligomerization domain containing 2, transcript variant X1
nucleotide binding oligomerization domain containing 2, transcript variant X2
nucleotide binding oligomerization domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 4 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nucleotide binding oligomerization domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 4 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nucleotide-binding oligomerization domain-containing protein 2 isoform X2
nucleotide-binding oligomerization domain-containing protein 2 isoform X1
nucleotide-binding oligomerization domain-containing protein 2 isoform X4
nucleotide-binding oligomerization domain-containing protein 2 isoform X3
CYLD lysine 63 deubiquitinase, transcript variant X1
CYLD lysine 63 deubiquitinase, transcript variant X4
CYLD lysine 63 deubiquitinase, transcript variant X3
CYLD lysine 63 deubiquitinase, transcript variant X2
CYLD lysine 63 deubiquitinase, transcript variant X7
CYLD lysine 63 deubiquitinase, transcript variant X9
CYLD lysine 63 deubiquitinase, transcript variant X5
CYLD lysine 63 deubiquitinase, transcript variant X6
CYLD lysine 63 deubiquitinase, transcript variant X10
CYLD lysine 63 deubiquitinase, transcript variant X8
ubiquitin carboxyl-terminal hydrolase CYLD isoform X1
ubiquitin carboxyl-terminal hydrolase CYLD isoform X2
S-antigen protein-like, transcript variant X9
S-antigen protein-like, transcript variant X10
S-antigen protein-like, transcript variant X5
S-antigen protein-like, transcript variant X8
S-antigen protein-like, transcript variant X3
S-antigen protein-like, transcript variant X1
S-antigen protein-like, transcript variant X2
S-antigen protein-like, transcript variant X6
S-antigen protein-like, transcript variant X4
S-antigen protein-like, transcript variant X11
S-antigen protein-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
TOX high mobility group box family member 3, transcript variant X1
TOX high mobility group box family member 3, transcript variant X2
TOX high mobility group box family member 3 isoform X1
TOX high mobility group box family member 3 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
chromodomain helicase DNA binding protein 9, transcript variant X1
chromodomain helicase DNA binding protein 9, transcript variant X6
chromodomain helicase DNA binding protein 9, transcript variant X4
chromodomain helicase DNA binding protein 9, transcript variant X3
chromodomain helicase DNA binding protein 9, transcript variant X2
chromodomain helicase DNA binding protein 9, transcript variant X5
chromodomain-helicase-DNA-binding protein 9 isoform X1
chromodomain-helicase-DNA-binding protein 9 isoform X2
chromodomain helicase DNA binding protein 9, transcript variant X7
chromodomain-helicase-DNA-binding protein 9 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123625115, transcript variant X2
uncharacterized LOC123625115, transcript variant X5
uncharacterized LOC123625115, transcript variant X1
uncharacterized LOC123625115, transcript variant X6
uncharacterized LOC123625115, transcript variant X3
uncharacterized LOC123625115, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 33 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 23 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
sodium-dependent noradrenaline transporter
lysophosphatidylcholine acyltransferase 2, transcript variant X1
lysophosphatidylcholine acyltransferase 2 isoform X1
lysophosphatidylcholine acyltransferase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lysophosphatidylcholine acyltransferase 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: iroquois-class homeodomain protein IRX-6
iroquois-class homeodomain protein IRX-5
iroquois-class homeodomain protein IRX-3
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X1
alpha-ketoglutarate-dependent dioxygenase FTO isoform X1
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 110 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X6
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X3
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X4
alpha-ketoglutarate-dependent dioxygenase FTO isoform X3
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X2
alpha-ketoglutarate-dependent dioxygenase FTO isoform X2
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X7
alpha-ketoglutarate-dependent dioxygenase FTO isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00425
AKT interacting protein, transcript variant X5
AKT interacting protein, transcript variant X4
AKT interacting protein, transcript variant X2
AKT interacting protein, transcript variant X3
AKT interacting protein, transcript variant X1
AKT interacting protein, transcript variant X6
glucosamine-6-phosphate isomerase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 31 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
putative ankyrin repeat domain-containing protein 19, transcript variant X3
putative ankyrin repeat domain-containing protein 19, transcript variant X2
putative ankyrin repeat domain-containing protein 19, transcript variant X4
putative ankyrin repeat domain-containing protein 19, transcript variant X5
putative ankyrin repeat domain-containing protein 19, transcript variant X1
putative ankyrin repeat domain-containing protein 19 isoform X2
putative ankyrin repeat domain-containing protein 19 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
adenosine deaminase domain-containing protein 2
TATA-box binding protein associated factor, RNA polymerase I subunit C, transcript variant X1
TATA box-binding protein-associated factor RNA polymerase I subunit C isoform X1
TATA-box binding protein associated factor, RNA polymerase I subunit C, transcript variant X2
TATA box-binding protein-associated factor RNA polymerase I subunit C isoform X2
inactive hydroxysteroid dehydrogenase-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
membrane bound transcription factor peptidase, site 1
membrane-bound transcription factor site-1 protease
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 3 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
putative sodium-coupled neutral amino acid transporter 8
N-terminal EF-hand calcium binding protein 2, transcript variant X1
N-terminal EF-hand calcium binding protein 2, transcript variant X2
N-terminal EF-hand calcium binding protein 2, transcript variant X3
N-terminal EF-hand calcium-binding protein 2 isoform X1
N-terminal EF-hand calcium-binding protein 2 isoform X2
oxidative stress induced growth inhibitor 1
oxidative stress-induced growth inhibitor 1
malonyl-CoA decarboxylase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 352 ESTs, 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 313 ESTs, 2 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
17-beta-hydroxysteroid dehydrogenase type 2
short chain dehydrogenase/reductase family 42E, member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: short-chain dehydrogenase/reductase family 42E member 1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2
c-Maf inducing protein, transcript variant X1
c-Maf inducing protein, transcript variant X3
c-Maf inducing protein, transcript variant X2
polycystic kidney disease protein 1-like 2
glycine cleavage system H protein, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein C16orf46 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 79 ESTs, 7 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COX assembly mitochondrial protein 2 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 17 ESTs, 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WW domain containing oxidoreductase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 106 ESTs, 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WW domain-containing oxidoreductase isoform X1
WW domain containing oxidoreductase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 88 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WW domain-containing oxidoreductase isoform X2
WW domain containing oxidoreductase, transcript variant X3
WW domain-containing oxidoreductase isoform X3
WW domain containing oxidoreductase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WW domain-containing oxidoreductase isoform X4
WW domain containing oxidoreductase, transcript variant X5
WW domain-containing oxidoreductase isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 8 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
synaptic vesicle membrane protein VAT-1 homolog-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00398
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
peroxisomal coenzyme A diphosphatase NUDT7
ADAM metallopeptidase with thrombospondin type 1 motif 18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
A disintegrin and metalloproteinase with thrombospondin motifs 18
synaptonemal complex central element protein 1 like, transcript variant X3
synaptonemal complex central element protein 1 like, transcript variant X2
synaptonemal complex central element protein 1 like, transcript variant X1
synaptonemal complex central element protein 1-like isoform X3
synaptonemal complex central element protein 1-like isoform X2
synaptonemal complex central element protein 1-like isoform X1
MON1 homolog B, secretory trafficking associated, transcript variant X1
MON1 homolog B, secretory trafficking associated, transcript variant X3
MON1 homolog B, secretory trafficking associated, transcript variant X2
contactin associated protein family member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 11 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
contactin associated protein family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
contactin associated protein family member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 6 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
contactin associated protein family member 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
contactin associated protein family member 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
contactin associated protein family member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
contactin-associated protein-like 4 isoform X2
contactin-associated protein-like 4 isoform X4
contactin-associated protein-like 4 isoform X5
contactin-associated protein-like 4 isoform X6
contactin-associated protein-like 4 isoform X3
contactin-associated protein-like 4 isoform X1
oxysterol-binding protein-related protein 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 17 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
telomeric repeat-binding factor 2-interacting protein 1
lysyl-tRNA synthetase 1, transcript variant X2
lysyl-tRNA synthetase 1, transcript variant X1
lysyl-tRNA synthetase 1, transcript variant X3
adenosine deaminase tRNA specific 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenosine deaminase tRNA specific 1, transcript variant X3
adenosine deaminase tRNA specific 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenosine deaminase tRNA specific 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenosine deaminase tRNA specific 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenosine deaminase tRNA specific 1, transcript variant X4
adenosine deaminase tRNA specific 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenosine deaminase tRNA specific 1, transcript variant X1
tRNA-specific adenosine deaminase 1 isoform X5
tRNA-specific adenosine deaminase 1 isoform X6
tRNA-specific adenosine deaminase 1 isoform X3
tRNA-specific adenosine deaminase 1 isoform X4
tRNA-specific adenosine deaminase 1 isoform X1
tRNA-specific adenosine deaminase 1 isoform X2
adenosine deaminase tRNA specific 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tRNA-specific adenosine deaminase 1 isoform X7
GABA type A receptor associated protein like 2
gamma-aminobutyric acid receptor-associated protein-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
carbohydrate sulfotransferase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
carbohydrate sulfotransferase 6, transcript variant X2
carbohydrate sulfotransferase 6, transcript variant X3
transmembrane protein 231, transcript variant X1
transmembrane protein 231, transcript variant X2
transmembrane protein 170A, transcript variant X2
transmembrane protein 170A, transcript variant X1
transmembrane protein 170A, transcript variant X3
BCAR1 scaffold protein, Cas family member, transcript variant X2
breast cancer anti-estrogen resistance protein 1 isoform X2
BCAR1 scaffold protein, Cas family member, transcript variant X1
breast cancer anti-estrogen resistance protein 1 isoform X1
ZFP1 zinc finger protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 16 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ZFP1 zinc finger protein, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 17 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ZFP1 zinc finger protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 17 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ZFP1 zinc finger protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 36 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ZFP1 zinc finger protein, transcript variant X3
ZFP1 zinc finger protein, transcript variant X8
ZFP1 zinc finger protein, transcript variant X6
ZFP1 zinc finger protein, transcript variant X1
ZFP1 zinc finger protein, transcript variant X4
zinc finger protein 1 homolog isoform X2
zinc finger protein 1 homolog isoform X1
zinc finger protein 1 homolog isoform X3
probable D-lactate dehydrogenase, mitochondrial
uncharacterized LOC123625434, transcript variant X1
uncharacterized LOC123625434, transcript variant X2
zinc and ring finger 1, transcript variant X4
zinc and ring finger 1, transcript variant X1
zinc and ring finger 1, transcript variant X3
zinc and ring finger 1, transcript variant X2
WD repeat domain 59, transcript variant X1
WD repeat domain 59, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 66 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat domain 59, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 71 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat domain 59, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 76 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat domain 59, transcript variant X2
WD repeat domain 59, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 85 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat domain 59, transcript variant X3
WD repeat domain 59, transcript variant X4
mixed lineage kinase domain like pseudokinase, transcript variant X6
mixed lineage kinase domain like pseudokinase, transcript variant X2
mixed lineage kinase domain like pseudokinase, transcript variant X1
mixed lineage kinase domain like pseudokinase, transcript variant X3
mixed lineage kinase domain like pseudokinase, transcript variant X5
mixed lineage kinase domain like pseudokinase, transcript variant X4
mixed lineage kinase domain-like protein isoform X2
mixed lineage kinase domain-like protein isoform X1
ring finger and WD repeat domain 3, transcript variant X3
ring finger and WD repeat domain 3, transcript variant X2
ring finger and WD repeat domain 3, transcript variant X1
ring finger and WD repeat domain 3, transcript variant X4
COORDINATES: nucleotide motif:Rfam:12.0:RF01241
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 17 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
pyruvate dehydrogenase phosphatase regulatory subunit, transcript variant X1
pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial isoform X1
pyruvate dehydrogenase phosphatase regulatory subunit, transcript variant X2
pyruvate dehydrogenase phosphatase regulatory subunit, transcript variant X3
pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial isoform X2
pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial isoform X3
C-type lectin domain family 18 member A, transcript variant X2
C-type lectin domain family 18 member A, transcript variant X3
C-type lectin domain family 18 member A, transcript variant X5
C-type lectin domain family 18 member A, transcript variant X1
C-type lectin domain family 18 member A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C-type lectin domain family 18 member A isoform X2
C-type lectin domain family 18 member A isoform X4
C-type lectin domain family 18 member A isoform X1
C-type lectin domain family 18 member A isoform X3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 5 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
DEAD-box helicase 19A, transcript variant X1
DEAD-box helicase 19A, transcript variant X4
ATP-dependent RNA helicase DDX19A isoform X1
DEAD-box helicase 19A, transcript variant X2
ATP-dependent RNA helicase DDX19A isoform X2
DEAD-box helicase 19A, transcript variant X3
uncharacterized LOC123625448, transcript variant X1
uncharacterized LOC123625448, transcript variant X2
ATP-dependent RNA helicase DDX19A isoform X3
ST3 beta-galactoside alpha-2,3-sialyltransferase 2, transcript variant X2
ST3 beta-galactoside alpha-2,3-sialyltransferase 2, transcript variant X3
ST3 beta-galactoside alpha-2,3-sialyltransferase 2, transcript variant X1
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2 isoform X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins
component of oligomeric golgi complex 4, transcript variant X1
component of oligomeric golgi complex 4, transcript variant X2
conserved oligomeric Golgi complex subunit 4 isoform X1
conserved oligomeric Golgi complex subunit 4 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00611
MTSS I-BAR domain containing 2, transcript variant X1
MTSS I-BAR domain containing 2, transcript variant X5
MTSS I-BAR domain containing 2, transcript variant X2
MTSS I-BAR domain containing 2, transcript variant X4
MTSS I-BAR domain containing 2, transcript variant X3
VAC14 component of PIKFYVE complex, transcript variant X1
VAC14 component of PIKFYVE complex, transcript variant X2
HYDIN axonemal central pair apparatus protein, transcript variant X3
hydrocephalus-inducing protein homolog isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
HYDIN axonemal central pair apparatus protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
HYDIN axonemal central pair apparatus protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hydrocephalus-inducing protein homolog isoform X2
hydrocephalus-inducing protein homolog isoform X1
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123625462, transcript variant X2
uncharacterized protein LOC123625462 isoform X2
uncharacterized LOC123625462, transcript variant X1
uncharacterized protein LOC123625462 isoform X1
uncharacterized LOC123625462, transcript variant X3
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 23, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 27 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 23, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 27 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 23, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 28 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 23, transcript variant X1
zinc finger protein 23, transcript variant X3
zinc finger protein 23, transcript variant X5
zinc finger protein 19, transcript variant X1
zinc finger protein 19, transcript variant X2
zinc finger protein 19, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 6 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
MARVEL domain containing 3, transcript variant X1
MARVEL domain containing 3, transcript variant X2
MARVEL domain containing 3, transcript variant X3
MARVEL domain-containing protein 3 isoform X1
MARVEL domain-containing protein 3 isoform X2
MARVEL domain-containing protein 3 isoform X3
PH domain and leucine rich repeat protein phosphatase 2
PH domain leucine-rich repeat-containing protein phosphatase 2
adaptor related protein complex 1 subunit gamma 1, transcript variant X2
adaptor related protein complex 1 subunit gamma 1, transcript variant X1
adaptor related protein complex 1 subunit gamma 1, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00576
COORDINATES: nucleotide motif:Rfam:12.0:RF00066
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
zinc finger protein 821, transcript variant X1
zinc finger protein 821, transcript variant X7
zinc finger protein 821, transcript variant X4
zinc finger protein 821, transcript variant X10
zinc finger protein 821, transcript variant X3
zinc finger protein 821, transcript variant X2
zinc finger protein 821, transcript variant X9
zinc finger protein 821, transcript variant X6
zinc finger protein 821, transcript variant X11
zinc finger protein 821, transcript variant X5
zinc finger protein 821, transcript variant X8
IST1 factor associated with ESCRT-III, transcript variant X1
IST1 factor associated with ESCRT-III, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1236 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polycystin 1 like 3, transient receptor potential channel interacting
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 83% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
dihydroorotate dehydrogenase (quinone), transcript variant X1
dihydroorotate dehydrogenase (quinone), transcript variant X2
dihydroorotate dehydrogenase (quinone), mitochondrial isoform X1
dihydroorotate dehydrogenase (quinone), mitochondrial isoform X2
thioredoxin like 4B, transcript variant X1
thioredoxin like 4B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DEAH-box helicase 38, transcript variant X1
DEAH-box helicase 38, transcript variant X2
pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 isoform X1
DEAH-box helicase 38, transcript variant X3
pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 isoform X2
polyamine modulated factor 1 binding protein 1
polyamine-modulated factor 1-binding protein 1
zinc finger homeobox 3, transcript variant X2
zinc finger homeobox 3, transcript variant X1
zinc finger homeobox protein 3 isoform X2
zinc finger homeobox protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 7
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X1
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X2
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X3
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X5
NEDD4-like E3 ubiquitin-protein ligase WWP2 isoform X1
NEDD4-like E3 ubiquitin-protein ligase WWP2 isoform X3
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 180 ESTs, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NEDD4-like E3 ubiquitin-protein ligase WWP2 isoform X2
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 128 ESTs, 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NEDD4-like E3 ubiquitin-protein ligase WWP2 isoform X4
NIN1 (RPN12) binding protein 1 homolog, transcript variant X1
NIN1 (RPN12) binding protein 1 homolog, transcript variant X2
nuclear factor of activated T cells 5, transcript variant X5
nuclear factor of activated T cells 5, transcript variant X1
nuclear factor of activated T cells 5, transcript variant X6
nuclear factor of activated T cells 5, transcript variant X4
nuclear factor of activated T cells 5, transcript variant X2
nuclear factor of activated T cells 5, transcript variant X3
nuclear factor of activated T cells 5, transcript variant X7
nuclear factor of activated T-cells 5 isoform X6
nuclear factor of activated T-cells 5 isoform X5
nuclear factor of activated T-cells 5 isoform X4
nuclear factor of activated T-cells 5 isoform X2
nuclear factor of activated T-cells 5 isoform X3
nuclear factor of activated T-cells 5 isoform X1
nuclear factor of activated T-cells 5 isoform X7
telomeric repeat binding factor 2, transcript variant X1
telomeric repeat binding factor 2, transcript variant X2
telomeric repeat-binding factor 2 isoform X1
telomeric repeat-binding factor 2 isoform X2
transmembrane emp24 domain-containing protein 6
nucleolar pre-rRNA processing protein NIP7
60S ribosome subunit biogenesis protein NIP7 homolog
component of oligomeric golgi complex 8, transcript variant X2
component of oligomeric golgi complex 8, transcript variant X1
conserved oligomeric Golgi complex subunit 8 isoform X2
conserved oligomeric Golgi complex subunit 8 isoform X1
vacuolar protein sorting 4 homolog A, transcript variant X2
vacuolar protein sorting 4 homolog A, transcript variant X1
vacuolar protein sorting-associated protein 4A isoform X2
vacuolar protein sorting-associated protein 4A isoform X1
U3 small nucleolar RNA-associated protein 4 homolog
chromosome transmission fidelity factor 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 140 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromosome transmission fidelity protein 8 homolog
DERPC proline and glycine rich nuclear protein
decreased expression in renal and prostate cancer protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
transport and golgi organization 6 homolog, transcript variant X1
transport and golgi organization 6 homolog, transcript variant X3
transport and Golgi organization protein 6 homolog isoform X1
transport and Golgi organization protein 6 homolog isoform X3
transport and golgi organization 6 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 ESTs, 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transport and Golgi organization protein 6 homolog isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01233
ZFP90 zinc finger protein, transcript variant X2
ZFP90 zinc finger protein, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: sphingomyelin phosphodiesterase 3
protein arginine methyltransferase 7, transcript variant X10
protein arginine methyltransferase 7, transcript variant X7
protein arginine methyltransferase 7, transcript variant X6
protein arginine methyltransferase 7, transcript variant X5
protein arginine methyltransferase 7, transcript variant X4
protein arginine methyltransferase 7, transcript variant X9
protein arginine methyltransferase 7, transcript variant X8
protein arginine methyltransferase 7, transcript variant X1
protein arginine methyltransferase 7, transcript variant X3
protein arginine methyltransferase 7, transcript variant X11
protein arginine methyltransferase 7, transcript variant X2
protein arginine methyltransferase 7, transcript variant X12
protein arginine N-methyltransferase 7 isoform X2
protein arginine N-methyltransferase 7 isoform X1
protein arginine N-methyltransferase 7 isoform X3
protein arginine N-methyltransferase 7 isoform X4
solute carrier family 7 member 6 opposite strand
probable RNA polymerase II nuclear localization protein SLC7A6OS
solute carrier family 7 member 6, transcript variant X1
solute carrier family 7 member 6, transcript variant X3
solute carrier family 7 member 6, transcript variant X2
phospholipase A2 group XV, transcript variant X4
phospholipase A2 group XV, transcript variant X3
phospholipase A2 group XV, transcript variant X6
phospholipase A2 group XV, transcript variant X1
phospholipase A2 group XV, transcript variant X2
phospholipase A2 group XV, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 100 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
epithelial splicing regulatory protein 2, transcript variant X1
epithelial splicing regulatory protein 2, transcript variant X6
epithelial splicing regulatory protein 2, transcript variant X2
epithelial splicing regulatory protein 2, transcript variant X3
epithelial splicing regulatory protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
epithelial splicing regulatory protein 2, transcript variant X4
epithelial splicing regulatory protein 2 isoform X5
epithelial splicing regulatory protein 2 isoform X1
epithelial splicing regulatory protein 2 isoform X2
epithelial splicing regulatory protein 2 isoform X3
epithelial splicing regulatory protein 2 isoform X4
nuclear factor of activated T cells 3, transcript variant X1
nuclear factor of activated T cells 3, transcript variant X3
nuclear factor of activated T-cells, cytoplasmic 3 isoform X1
nuclear factor of activated T-cells, cytoplasmic 3 isoform X3
nuclear factor of activated T cells 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 215 ESTs, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
dihydrouridine synthase 2, transcript variant X2
dihydrouridine synthase 2, transcript variant X1
dihydrouridine synthase 2, transcript variant X4
dihydrouridine synthase 2, transcript variant X5
dihydrouridine synthase 2, transcript variant X7
dihydrouridine synthase 2, transcript variant X3
dihydrouridine synthase 2, transcript variant X6
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X2
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X1
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X3
probable ATP-dependent RNA helicase DDX28
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
core-binding factor subunit beta, transcript variant X1
core-binding factor subunit beta, transcript variant X2
core-binding factor subunit beta isoform X1
core-binding factor subunit beta isoform X2
uncharacterized LOC123625183, transcript variant X2
uncharacterized LOC123625183, transcript variant X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9
TNFRSF1A associated via death domain, transcript variant X2
TNFRSF1A associated via death domain, transcript variant X1
tumor necrosis factor receptor type 1-associated DEATH domain protein isoform X1
tumor necrosis factor receptor type 1-associated DEATH domain protein isoform X2
F-box and leucine rich repeat protein 8, transcript variant X2
F-box and leucine rich repeat protein 8, transcript variant X3
F-box and leucine rich repeat protein 8, transcript variant X1
heat shock transcription factor 4, transcript variant X1
heat shock transcription factor 4, transcript variant X5
heat shock transcription factor 4, transcript variant X2
heat shock transcription factor 4, transcript variant X4
heat shock transcription factor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nucleolar protein 3, transcript variant X1
nucleolar protein 3, transcript variant X3
nucleolar protein 3, transcript variant X2
uncharacterized protein KIAA0895-like homolog isoform X2
uncharacterized protein KIAA0895-like homolog isoform X3
uncharacterized protein KIAA0895-like homolog isoform X1
uncharacterized protein KIAA0895-like homolog isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 ESTs, 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein KIAA0895-like homolog isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 2 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
exocyst complex component 3-like protein
leucine-rich repeat-containing protein 29-like, transcript variant X3
leucine-rich repeat-containing protein 29-like, transcript variant X1
leucine-rich repeat-containing protein 29-like, transcript variant X2
leucine-rich repeat-containing protein 29-like, transcript variant X5
leucine-rich repeat-containing protein 29-like, transcript variant X4
F-box/LRR-repeat protein 2-like isoform X2
F-box/LRR-repeat protein 20-like isoform X3
F-box/LRR-repeat protein 2-like isoform X1
leucine-rich repeat-containing protein 29-like isoform X4
formin homology 2 domain containing 1, transcript variant X1
formin homology 2 domain containing 1, transcript variant X2
formin homology 2 domain containing 1, transcript variant X3
formin homology 2 domain containing 1, transcript variant X4
FH1/FH2 domain-containing protein 1 isoform X2
FH1/FH2 domain-containing protein 1 isoform X1
FH1/FH2 domain-containing protein 1 isoform X3
formin homology 2 domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FH1/FH2 domain-containing protein 1 isoform X4
solute carrier family 9 member A5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 9 member A5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123625199, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123625199, transcript variant X1
pleckstrin homology and RhoGEF domain containing G4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 ESTs, 8 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
potassium channel tetramerization domain containing 19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 ESTs, 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
BTB/POZ domain-containing protein KCTD19
leucine rich repeat containing 36, transcript variant X2
leucine rich repeat containing 36, transcript variant X1
leucine-rich repeat-containing protein 36 isoform X1
leucine-rich repeat-containing protein 36 isoform X2
tubulin polymerization promoting protein family member 3, transcript variant X1
tubulin polymerization promoting protein family member 3, transcript variant X2
tubulin polymerization-promoting protein family member 3
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
zinc finger DHHC-type containing 1, transcript variant X3
zinc finger DHHC-type containing 1, transcript variant X4
zinc finger DHHC-type containing 1, transcript variant X2
zinc finger DHHC-type containing 1, transcript variant X7
zinc finger DHHC-type containing 1, transcript variant X5
zinc finger DHHC-type containing 1, transcript variant X6
zinc finger DHHC-type containing 1, transcript variant X1
corticosteroid 11-beta-dehydrogenase isozyme 2
RHO family interacting cell polarization regulator 1, transcript variant X4
RHO family interacting cell polarization regulator 1, transcript variant X3
uncharacterized LOC123625215, transcript variant X2
uncharacterized LOC123625215, transcript variant X3
uncharacterized LOC123625215, transcript variant X1
RHO family interacting cell polarization regulator 1, transcript variant X1
RHO family interacting cell polarization regulator 1, transcript variant X2
RHO family interacting cell polarization regulator 1, transcript variant X5
rho family-interacting cell polarization regulator 1 isoform X1
rho family-interacting cell polarization regulator 1 isoform X2
rho family-interacting cell polarization regulator 1 isoform X4
rho family-interacting cell polarization regulator 1 isoform X3
CCCTC-binding factor, transcript variant X1
CCCTC-binding factor, transcript variant X3
CCCTC-binding factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
transcriptional repressor CTCF isoform X1
transcriptional repressor CTCF isoform X2
capping protein regulator and myosin 1 linker 2, transcript variant X4
capping protein regulator and myosin 1 linker 2, transcript variant X5
capping protein regulator and myosin 1 linker 2, transcript variant X1
capping protein regulator and myosin 1 linker 2, transcript variant X2
capping protein regulator and myosin 1 linker 2, transcript variant X3
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X1
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X2
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X3
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X4
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X5
ACD shelterin complex subunit and telomerase recruitment factor
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
LOW QUALITY PROTEIN: adrenocortical dysplasia protein homolog
par-6 family cell polarity regulator alpha, transcript variant X2
par-6 family cell polarity regulator alpha, transcript variant X1
par-6 family cell polarity regulator alpha, transcript variant X3
partitioning defective 6 homolog alpha isoform X1
partitioning defective 6 homolog alpha isoform X2
partitioning defective 6 homolog alpha isoform X3
enkurin domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
enkurin domain containing 1, transcript variant X3
par-6 family cell polarity regulator alpha, transcript variant X5
par-6 family cell polarity regulator alpha, transcript variant X4
partitioning defective 6 homolog alpha isoform X4
partitioning defective 6 homolog alpha isoform X5
enkurin domain-containing protein 1 isoform X2
enkurin domain containing 1, transcript variant X1
enkurin domain-containing protein 1 isoform X1
enkurin domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
enkurin domain-containing protein 1 isoform X3
uncharacterized protein C16orf86 homolog
glucose-fructose oxidoreductase domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 ESTs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glucose-fructose oxidoreductase domain containing 2, transcript variant X1
glucose-fructose oxidoreductase domain containing 2, transcript variant X4
glucose-fructose oxidoreductase domain containing 2, transcript variant X2
glucose-fructose oxidoreductase domain-containing protein 2 isoform X2
glucose-fructose oxidoreductase domain-containing protein 2 isoform X1
translin associated factor X interacting protein 1, transcript variant X6
translin associated factor X interacting protein 1, transcript variant X3
translin associated factor X interacting protein 1, transcript variant X4
translin associated factor X interacting protein 1, transcript variant X1
translin-associated factor X-interacting protein 1 isoform X1
translin-associated factor X-interacting protein 1 isoform X3
translin-associated factor X-interacting protein 1 isoform X5
translin associated factor X interacting protein 1, transcript variant X2
translin-associated factor X-interacting protein 1 isoform X2
translin associated factor X interacting protein 1, transcript variant X5
translin-associated factor X-interacting protein 1 isoform X4
centromere protein T, transcript variant X4
centromere protein T, transcript variant X2
centromere protein T, transcript variant X3
centromere protein T, transcript variant X1
enhancer of mRNA decapping 4, transcript variant X3
enhancer of mRNA decapping 4, transcript variant X1
enhancer of mRNA decapping 4, transcript variant X2
enhancer of mRNA-decapping protein 4 isoform X2
enhancer of mRNA-decapping protein 4 isoform X1
enhancer of mRNA-decapping protein 4 isoform X3
protein serine kinase H1, transcript variant X1
protein serine kinase H1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 25 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein serine kinase H1, transcript variant X4
protein serine kinase H1, transcript variant X3
serine/threonine-protein kinase H1 isoform X1
serine/threonine-protein kinase H1 isoform X2
lecithin-cholesterol acyltransferase, transcript variant X1
lecithin-cholesterol acyltransferase, transcript variant X2
phosphatidylcholine-sterol acyltransferase isoform X1
phosphatidylcholine-sterol acyltransferase isoform X2
solute carrier family 12 member 4, transcript variant X2
solute carrier family 12 member 4, transcript variant X1
solute carrier family 12 member 4 isoform X2
solute carrier family 12 member 4 isoform X1
solute carrier family 12 member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 189 ESTs, 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 14 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
dipeptidase 2-like, transcript variant X1
dipeptidase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123625244, transcript variant X2
uncharacterized LOC123625244, transcript variant X1
carboxylesterase 3, transcript variant X1
carboxylesterase 3, transcript variant X2
cytosolic iron-sulfur assembly component 2B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 23 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
pyruvate dehyrogenase phosphatase catalytic subunit 2
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 2, mitochondrial
NEDD8 activating enzyme E1 subunit 1, transcript variant X2
NEDD8-activating enzyme E1 regulatory subunit isoform X2
carbonic anhydrase 7, transcript variant X1
carbonic anhydrase 7, transcript variant X2
NEDD8 activating enzyme E1 subunit 1, transcript variant X1
NEDD8-activating enzyme E1 regulatory subunit isoform X1
telomere repeat binding bouquet formation protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
telomere repeats-binding bouquet formation protein 1
dynein cytoplasmic 1 light intermediate chain 2
cytoplasmic dynein 1 light intermediate chain 2
CKLF like MARVEL transmembrane domain containing 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 21 ESTs, 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CKLF-like MARVEL transmembrane domain-containing protein 4
CKLF like MARVEL transmembrane domain containing 3, transcript variant X1
CKLF-like MARVEL transmembrane domain-containing protein 3 isoform X1
CKLF like MARVEL transmembrane domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 81 ESTs, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CKLF-like MARVEL transmembrane domain-containing protein 3 isoform X2
CKLF like MARVEL transmembrane domain containing 2
CKLF-like MARVEL transmembrane domain-containing protein 2
chemokine-like factor, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
chemokine-like factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chemokine-like factor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC123624980 isoform X1
CKLF-like MARVEL transmembrane domain-containing protein 2 isoform X5
chemokine-like factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC123624980 isoform X3
chemokine-like factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chemokine-like factor, transcript variant X2
uncharacterized protein LOC123624980 isoform X2
chemokine-like factor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 4 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 187 ESTs, 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 19 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
aspartate aminotransferase, mitochondrial
solute carrier family 38 member 7, transcript variant X1
solute carrier family 38 member 7, transcript variant X3
solute carrier family 38 member 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 38 member 7, transcript variant X2
putative sodium-coupled neutral amino acid transporter 7
CCR4-NOT transcription complex subunit 1, transcript variant X1
CCR4-NOT transcription complex subunit 1, transcript variant X5
CCR4-NOT transcription complex subunit 1, transcript variant X3
CCR4-NOT transcription complex subunit 1, transcript variant X7
CCR4-NOT transcription complex subunit 1, transcript variant X2
CCR4-NOT transcription complex subunit 1, transcript variant X6
CCR4-NOT transcription complex subunit 1, transcript variant X4
CCR4-NOT transcription complex subunit 1, transcript variant X9
CCR4-NOT transcription complex subunit 1 isoform X1
CCR4-NOT transcription complex subunit 1 isoform X5
CCR4-NOT transcription complex subunit 1 isoform X3
CCR4-NOT transcription complex subunit 1 isoform X7
CCR4-NOT transcription complex subunit 1 isoform X2
CCR4-NOT transcription complex subunit 1 isoform X6
CCR4-NOT transcription complex subunit 1 isoform X4
CCR4-NOT transcription complex subunit 1 isoform X9
CCR4-NOT transcription complex subunit 1, transcript variant X8
CCR4-NOT transcription complex subunit 1 isoform X8
COORDINATES: nucleotide motif:Rfam:12.0:RF00407
COORDINATES: nucleotide motif:Rfam:12.0:RF00404
SET domain containing 6, protein lysine methyltransferase
NDRG family member 4, transcript variant X4
NDRG family member 4, transcript variant X5
NDRG family member 4, transcript variant X6
NDRG family member 4, transcript variant X1
NDRG family member 4, transcript variant X3
NDRG family member 4, transcript variant X2
GINS complex subunit 3, transcript variant X1
GINS complex subunit 3, transcript variant X2
DNA replication complex GINS protein PSF3 isoform X2
DNA replication complex GINS protein PSF3 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: inactive serine protease 54
coiled-coil domain containing 113, transcript variant X3
coiled-coil domain containing 113, transcript variant X2
coiled-coil domain containing 113, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coiled-coil domain-containing protein 113 isoform X2
coiled-coil domain-containing protein 113 isoform X1
coiled-coil domain-containing protein 113 isoform X3
casein kinase 2 alpha 2, transcript variant X1
casein kinase 2 alpha 2, transcript variant X2
casein kinase II subunit alpha' isoform X1
casein kinase II subunit alpha' isoform X2
cilia and flagella associated protein 20
cilia- and flagella-associated protein 20
U6 snRNA biogenesis phosphodiesterase 1, transcript variant X2
U6 snRNA biogenesis phosphodiesterase 1, transcript variant X1
zinc finger protein 319, transcript variant X1
zinc finger protein 319, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 319, transcript variant X2
zinc finger protein 319, transcript variant X4
zinc finger protein 319, transcript variant X5
testis, prostate and placenta-expressed protein
cyclic nucleotide gated channel subunit beta 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 4 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
cyclic nucleotide-gated cation channel beta-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
kinesin family member C3, transcript variant X3
kinesin family member C3, transcript variant X4
kinesin family member C3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 56 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kinesin family member C3, transcript variant X2
kinesin family member C3, transcript variant X1
kinesin family member C3, transcript variant X6
kinesin family member C3, transcript variant X7
kinesin family member C3, transcript variant X8
katanin regulatory subunit B1, transcript variant X2
katanin regulatory subunit B1, transcript variant X1
katanin p80 WD40 repeat-containing subunit B1
dynein regulatory complex subunit 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dynein regulatory complex subunit 7, transcript variant X1
dynein regulatory complex subunit 7, transcript variant X3
dynein regulatory complex subunit 7 isoform X2
dynein regulatory complex subunit 7 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adhesion G protein-coupled receptor G1, transcript variant X2
adhesion G protein-coupled receptor G1, transcript variant X3
adhesion G protein-coupled receptor G1, transcript variant X1
adhesion G protein-coupled receptor G1, transcript variant X4
adhesion G-protein coupled receptor G1 isoform X2
adhesion G-protein coupled receptor G1 isoform X1
uncharacterized LOC123625276, transcript variant X2
uncharacterized LOC123625276, transcript variant X1
adhesion G protein-coupled receptor G5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adhesion G protein-coupled receptor G5, transcript variant X6
adhesion G protein-coupled receptor G5, transcript variant X2
adhesion G protein-coupled receptor G5, transcript variant X1
adhesion G protein-coupled receptor G5, transcript variant X3
adhesion G protein-coupled receptor G5, transcript variant X4
adhesion G-protein coupled receptor G5 isoform X1
adhesion G-protein coupled receptor G5 isoform X2
coiled-coil domain-containing protein 102A
docking protein 4, transcript variant X2
docking protein 4, transcript variant X1
docking protein 4, transcript variant X3
DNA-directed RNA polymerase II subunit RPB3
ubiquinone biosynthesis protein COQ9, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ADP ribosylation factor like GTPase 2 binding protein
ADP-ribosylation factor-like protein 2-binding protein
ring finger and SPRY domain containing 1, transcript variant X3
ring finger and SPRY domain containing 1, transcript variant X2
ring finger and SPRY domain containing 1, transcript variant X4
ring finger and SPRY domain containing 1, transcript variant X1
RING finger and SPRY domain-containing protein 1
proteasome activator subunit 3 interacting protein 1, transcript variant X4
proteasome activator subunit 3 interacting protein 1, transcript variant X2
proteasome activator subunit 3 interacting protein 1, transcript variant X3
proteasome activator subunit 3 interacting protein 1, transcript variant X1
proteasome activator subunit 3 interacting protein 1, transcript variant X5
NLR family CARD domain containing 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NLR family CARD domain containing 5, transcript variant X6
NLR family CARD domain containing 5, transcript variant X3
NLR family CARD domain containing 5, transcript variant X5
NLR family CARD domain containing 5, transcript variant X1
NLR family CARD domain containing 5, transcript variant X4
NLR family CARD domain containing 5, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123625295, transcript variant X1
uncharacterized LOC123625295, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 490 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
homocysteine inducible ER protein with ubiquitin like domain 1, transcript variant X1
homocysteine inducible ER protein with ubiquitin like domain 1, transcript variant X2
homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform X2
homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform X1
solute carrier family 12 member 3, transcript variant X2
solute carrier family 12 member 3, transcript variant X5
solute carrier family 12 member 3, transcript variant X1
solute carrier family 12 member 3, transcript variant X4
solute carrier family 12 member 3 isoform X2
solute carrier family 12 member 3 isoform X5
solute carrier family 12 member 3 isoform X1
solute carrier family 12 member 3 isoform X4
solute carrier family 12 member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 12 member 3 isoform X3
uncharacterized LOC123625310, transcript variant X2
uncharacterized LOC123625310, transcript variant X3
uncharacterized LOC123625310, transcript variant X1
2-oxoglutarate and iron dependent oxygenase domain containing 1
cleavage and polyadenylation specificity factor subunit 5
G protein subunit alpha o1, transcript variant X1
guanine nucleotide-binding protein G(o) subunit alpha isoform X1
G protein subunit alpha o1, transcript variant X2
guanine nucleotide-binding protein G(o) subunit alpha isoform X2
carboxylesterase 5A, transcript variant X2
carboxylesterase 5A, transcript variant X1
potassium voltage-gated channel modifier subfamily G member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily G member 4
LOW QUALITY PROTEIN: WAP four-disulfide core domain protein 1
ATPase secretory pathway Ca2+ transporting 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium-transporting ATPase type 2C member 2
MTOR associated protein, eak-7 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 25 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MTOR associated protein, eak-7 homolog, transcript variant X2
MTOR associated protein, eak-7 homolog, transcript variant X1
MTOR-associated protein MEAK7 isoform X2
MTOR-associated protein MEAK7 isoform X1
MTOR-associated protein MEAK7 isoform X3
coactosin like F-actin binding protein 1
kelch like family member 36, transcript variant X2
kelch like family member 36, transcript variant X1
ubiquitin specific peptidase 10, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 10 isoform X1
ubiquitin specific peptidase 10, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 10 isoform X2
cysteine rich secretory protein LCCL domain containing 2, transcript variant X1
cysteine rich secretory protein LCCL domain containing 2, transcript variant X2
cysteine-rich secretory protein LCCL domain-containing 2
uncharacterized LOC123625326, transcript variant X1
uncharacterized LOC123625326, transcript variant X3
uncharacterized LOC123625326, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 7, transcript variant X3
zinc finger DHHC-type palmitoyltransferase 7, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 7, transcript variant X2
KIAA0513 ortholog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 24 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
KIAA0513 ortholog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 27 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
KIAA0513 ortholog, transcript variant X3
KIAA0513 ortholog, transcript variant X2
uncharacterized protein KIAA0513 homolog isoform X1
uncharacterized protein KIAA0513 homolog isoform X2
CBY1 interacting BAR domain containing 2, transcript variant X3
CBY1 interacting BAR domain containing 2, transcript variant X1
CBY1 interacting BAR domain containing 2, transcript variant X2
CBY1-interacting BAR domain-containing protein 2 isoform X2
CBY1-interacting BAR domain-containing protein 2 isoform X3
CBY1-interacting BAR domain-containing protein 2 isoform X1
uncharacterized LOC123625330, transcript variant X1
uncharacterized LOC123625330, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 74% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123625332, transcript variant X1
uncharacterized LOC123625332, transcript variant X2
Gse1 coiled-coil protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Gse1 coiled-coil protein, transcript variant X1
Gse1 coiled-coil protein, transcript variant X4
Gse1 coiled-coil protein, transcript variant X2
Gse1 coiled-coil protein, transcript variant X5
DNA replication complex GINS protein PSF2
chromosome 20 C16orf74 homolog, transcript variant X2
chromosome 20 C16orf74 homolog, transcript variant X3
chromosome 20 C16orf74 homolog, transcript variant X1
uncharacterized protein C16orf74 homolog isoform X3
uncharacterized protein C16orf74 homolog isoform X2
uncharacterized protein C16orf74 homolog isoform X1
cytochrome c oxidase subunit 4 isoform 1, mitochondrial
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
uncharacterized LOC123624965, transcript variant X3
uncharacterized LOC123624965, transcript variant X1
uncharacterized LOC123624965, transcript variant X2
methenyltetrahydrofolate synthetase domain containing, transcript variant X3
methenyltetrahydrofolate synthase domain-containing protein isoform X3
methenyltetrahydrofolate synthetase domain containing, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
methenyltetrahydrofolate synthetase domain containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 40 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
methenyltetrahydrofolate synthetase domain containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 35 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
methenyltetrahydrofolate synthase domain-containing protein isoform X4
methenyltetrahydrofolate synthase domain-containing protein isoform X1
methenyltetrahydrofolate synthase domain-containing protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C16orf95 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
microtubule associated protein 1 light chain 3 beta
microtubule-associated proteins 1A/1B light chain 3B
zinc finger CCHC-type containing 14, transcript variant X4
zinc finger CCHC-type containing 14, transcript variant X3
zinc finger CCHC-type containing 14, transcript variant X2
zinc finger CCHC-type containing 14, transcript variant X1
zinc finger CCHC domain-containing protein 14 isoform X2
zinc finger CCHC domain-containing protein 14 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 10 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
kelch domain containing 4, transcript variant X4
kelch domain containing 4, transcript variant X3
kelch domain containing 4, transcript variant X5
kelch domain containing 4, transcript variant X2
kelch domain containing 4, transcript variant X1
kelch domain containing 4, transcript variant X7
kelch domain containing 4, transcript variant X6
kelch domain-containing protein 4 isoform X1
kelch domain-containing protein 4 isoform X2
large neutral amino acids transporter small subunit 1
carbonic anhydrase 5A, mitochondrial-like
BTG3 associated nuclear protein, transcript variant X6
BTG3 associated nuclear protein, transcript variant X10
BTG3 associated nuclear protein, transcript variant X11
BTG3 associated nuclear protein, transcript variant X12
BTG3 associated nuclear protein, transcript variant X8
BTG3 associated nuclear protein, transcript variant X3
BTG3 associated nuclear protein, transcript variant X5
BTG3 associated nuclear protein, transcript variant X1
BTG3 associated nuclear protein, transcript variant X4
BTG3 associated nuclear protein, transcript variant X2
BTG3 associated nuclear protein, transcript variant X7
BTG3 associated nuclear protein, transcript variant X9
BTG3 associated nuclear protein, transcript variant X13
zinc finger CCCH-type containing 18, transcript variant X1
zinc finger CCCH-type containing 18, transcript variant X2
zinc finger CCCH-type containing 18, transcript variant X3
zinc finger CCCH-type containing 18, transcript variant X5
zinc finger CCCH-type containing 18, transcript variant X6
zinc finger CCCH-type containing 18, transcript variant X4
zinc finger CCCH domain-containing protein 18 isoform X1
zinc finger CCCH domain-containing protein 18 isoform X2
zinc finger CCCH domain-containing protein 18 isoform X3
cytochrome b-245 light chain, transcript variant X2
cytochrome b-245 light chain, transcript variant X1
mevalonate diphosphate decarboxylase, transcript variant X2
mevalonate diphosphate decarboxylase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 122 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
diphosphomevalonate decarboxylase isoform X2
diphosphomevalonate decarboxylase isoform X1
snail family transcriptional repressor 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
cytosolic thiouridylase subunit 2, transcript variant X1
cytosolic thiouridylase subunit 2, transcript variant X2
cytosolic thiouridylase subunit 2, transcript variant X3
cytoplasmic tRNA 2-thiolation protein 2 isoform X1
cytoplasmic tRNA 2-thiolation protein 2 isoform X2
cytoplasmic tRNA 2-thiolation protein 2 isoform X3
piezo type mechanosensitive ion channel component 1, transcript variant X1
piezo type mechanosensitive ion channel component 1, transcript variant X2
piezo-type mechanosensitive ion channel component 1 isoform X2
piezo-type mechanosensitive ion channel component 1 isoform X1
chromatin licensing and DNA replication factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: N-acetylgalactosamine-6-sulfatase
trafficking protein particle complex subunit 2L, transcript variant X1
trafficking protein particle complex subunit 2L, transcript variant X2
trafficking protein particle complex subunit 2-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
embryonic polyadenylate-binding protein 2
CBFA2/RUNX1 partner transcriptional co-repressor 3, transcript variant X2
CBFA2/RUNX1 partner transcriptional co-repressor 3, transcript variant X1
acyl-CoA synthetase family member 3, transcript variant X3
acyl-CoA synthetase family member 3, transcript variant X1
acyl-CoA synthetase family member 3, transcript variant X2
acyl-CoA synthetase family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X5
malonate--CoA ligase ACSF3, mitochondrial isoform X2
malonate--CoA ligase ACSF3, mitochondrial isoform X4
malonate--CoA ligase ACSF3, mitochondrial isoform X1
malonate--CoA ligase ACSF3, mitochondrial isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, and 24% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 778, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 778, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 778, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123625394, transcript variant X2
uncharacterized LOC123625394, transcript variant X1
ankyrin repeat domain containing 11, transcript variant X2
ankyrin repeat domain containing 11, transcript variant X1
ankyrin repeat domain containing 11, transcript variant X3
ankyrin repeat domain containing 11, transcript variant X5
ankyrin repeat domain containing 11, transcript variant X4
ankyrin repeat domain containing 11, transcript variant X6
ankyrin repeat domain-containing protein 11 isoform X1
ankyrin repeat domain-containing protein 11 isoform X2
uncharacterized LOC123625395, transcript variant X2
uncharacterized LOC123625395, transcript variant X1
SPG7 matrix AAA peptidase subunit, paraplegin
COORDINATES: nucleotide motif:Rfam:12.0:RF00324
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 14 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
spermatogenesis associated 33, transcript variant X3
spermatogenesis associated 33, transcript variant X2
spermatogenesis associated 33, transcript variant X1
spermatogenesis-associated protein 33 isoform X2
spermatogenesis-associated protein 33 isoform X1
cyclin dependent kinase 10, transcript variant X6
cyclin dependent kinase 10, transcript variant X10
cyclin dependent kinase 10, transcript variant X4
cyclin dependent kinase 10, transcript variant X7
cyclin dependent kinase 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cyclin dependent kinase 10, transcript variant X1
cyclin dependent kinase 10, transcript variant X2
cyclin dependent kinase 10, transcript variant X5
cyclin dependent kinase 10, transcript variant X12
cyclin dependent kinase 10, transcript variant X11
cyclin dependent kinase 10, transcript variant X9
cyclin dependent kinase 10, transcript variant X8
spermatogenesis associated 2 like, transcript variant X1
spermatogenesis associated 2 like, transcript variant X2
spermatogenesis-associated protein 2-like protein
VPS9 domain containing 1, transcript variant X1
VPS9 domain containing 1, transcript variant X6
VPS9 domain containing 1, transcript variant X2
VPS9 domain containing 1, transcript variant X5
VPS9 domain containing 1, transcript variant X4
VPS9 domain containing 1, transcript variant X3
VPS9 domain containing 1, transcript variant X8
VPS9 domain containing 1, transcript variant X9
VPS9 domain-containing protein 1 isoform X6
VPS9 domain-containing protein 1 isoform X2
VPS9 domain-containing protein 1 isoform X5
VPS9 domain-containing protein 1 isoform X4
VPS9 domain-containing protein 1 isoform X3
VPS9 domain-containing protein 1 isoform X1
VPS9 domain-containing protein 1 isoform X8
VPS9 domain containing 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
VPS9 domain-containing protein 1 isoform X7
LOW QUALITY PROTEIN: Fanconi anemia group A protein
LOW QUALITY PROTEIN: uncharacterized protein LOC123625104
growth arrest specific 8, transcript variant X1
growth arrest specific 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dysbindin domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dysbindin domain containing 1, transcript variant X2
differentially expressed in FDCP 8 homolog, transcript variant X7
differentially expressed in FDCP 8 homolog, transcript variant X3
differentially expressed in FDCP 8 homolog, transcript variant X2
differentially expressed in FDCP 8 homolog, transcript variant X5
differentially expressed in FDCP 8 homolog, transcript variant X4
differentially expressed in FDCP 8 homolog, transcript variant X1
differentially expressed in FDCP 8 homolog isoform X3
differentially expressed in FDCP 8 homolog isoform X2
differentially expressed in FDCP 8 homolog isoform X1
differentially expressed in FDCP 8 homolog isoform X5
differentially expressed in FDCP 8 homolog, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 27 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
differentially expressed in FDCP 8 homolog, transcript variant X6
differentially expressed in FDCP 8 homolog isoform X6
differentially expressed in FDCP 8 homolog isoform X4
transcription factor 25, transcript variant X1
transcription factor 25, transcript variant X2
LOW QUALITY PROTEIN: protein spire homolog 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 mRNAs, 1 EST, 7 Proteins, and 2% coverage of the annotated genomic feature by RNAseq alignments
histone-lysine N-methyltransferase PRDM7
uncharacterized LOC123624955, transcript variant X1
uncharacterized LOC123624955, transcript variant X6
uncharacterized LOC123624955, transcript variant X5
uncharacterized LOC123624955, transcript variant X4
uncharacterized LOC123624955, transcript variant X8
uncharacterized LOC123624955, transcript variant X3
uncharacterized LOC123624955, transcript variant X7
uncharacterized LOC123624955, transcript variant X2